Strategies for mosaic variant calling in brain disorders
Seungseok Kang1, Yujin Oh2, Sangwoo Kim3
1Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea.
Current Opinion in Genetics & Development
|July 30, 2026
Summary
Detecting low-frequency somatic mutations in the brain is challenging. This review highlights sequencing depth and algorithm choice as key for identifying genomic mosaicism driving brain diseases.
Area of Science:
- Genomics
- Neuroscience
- Molecular Biology
Background:
- The human brain exhibits genomic mosaicism due to postzygotic mutations, contributing to neurodevelopmental and neurodegenerative diseases.
- Detecting these ultralow variant allele frequency (VAF) mutations is analytically challenging due to sequencing artifacts.
Purpose of the Study:
- To review current strategies for detecting somatic variants in the brain.
- To emphasize the impact of sequencing depth and algorithm selection on variant detection sensitivity.
- To discuss multitissue sampling and multiomics integration for understanding brain health and disease.
Main Methods:
- Summarizing sampling methods like bulk, laser capture microdissection, and single-cell genomics.
- Evaluating variant calling algorithms (e.g., MuTect2, MosaicForecast) based on VAF detection performance.
- Discussing multitissue sampling approaches and integration with transcriptomic and epigenetic data.
Main Results:
- Mosaic detection sensitivity is fundamentally limited by sequencing depth.
- Algorithm selection should be based on validated VAF detection performance for optimal results.
- Multitissue sampling aids in accurate variant classification through cross-tissue VAF gradients.
Conclusions:
- Optimizing sampling methods and sequencing depth is crucial for detecting brain genomic mosaicism.
- Careful selection of variant calling algorithms tailored to VAF ranges improves detection accuracy.
- Integrating multiomics data with genomic findings will advance the functional understanding of somatic genome's role in brain disorders.


